FT Big Read

The opioid marketing machine

09.12.2018 - By Financial TimesPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Purdue Pharma faces more than 1,000 lawsuits claiming it ignited and fuelled the US opioid crisis, reports David Crow. Prosecutors say the company exaggerated the benefits of its painkiller OxyContin, but through their ownership of Rhodes Pharma, Purdue’s owners also have a far bigger market share than was realised. Hosted on Acast. See acast.com/privacy for more information.

More episodes from FT Big Read